Table 1.
Baseline characteristics for patients with an A-shaped SVS compared to those with an S-shaped SVS (S-SVS).
| All | S-SVS | A-SVS | p-value | |
|---|---|---|---|---|
| Number of patients | 62/62 (100%) | 27/62 (44%) | 35/62 (56%) | |
| Age, years (median, IQR) | 70 (57–77) | 72 (63–79) | 67 (55–76) | 0.960 |
| Female (%) | 33 (53%) | 14 (52%) | 19 (54%) | 1.000 |
| Medical history | ||||
| Hypertension (%) | 44 (71%) | 18 (67%) | 26 (74%) | 0.51 |
| Diabetes (%) | 16 (26%) | 8 (30%) | 8 (23%) | 0.41 |
| Hyperlipidemia | 30 (48%) | 11 (41%) | 19 (54%) | 0.33 |
| Atrial fibrillation (%) | 31 (50%) | 15 (56%) | 16 (46%) | 0.34 |
| Coronary artery disease (%) | 13 (21%) | 6 (22%) | 7 (20%) | 0.49 |
| Prior stroke (%) | 8 (13%) | 3 (11%) | 5 (14%) | 0.71 |
| Platelets | 195 (163–228) | 207 (171–240) | 179 (161–212) | 0.15 |
| Smoking | 0.16 | |||
| Never (%) | 35 (57%) | 17 (63%) | 18 (51%) | |
| Prior (%) | 19 (31%) | 9 (33%) | 10 (29%) | |
| Current (%) | 8 (13%) | 1 (4%) | 7 (20%) | |
| Stroke details | ||||
| Baseline NIHSS (median, IQR) | 16 (12–21) | 14 (10–20) | 17 (13–22) | 0.12 |
| Drugs and medications | ||||
| Antiplatelet or anticoagulant | 28 (45%) | 15 (56%) | 13 (36%) | 0.15 |
| Intravenous tPA (%) | 40 (65%) | 18 (67%) | 22 (63%) | 0.48 |